Alzheimer's Disease & ARIA Focus Group

Medical Learning Institute Inc (MLI) is an independent non-profit provider of evidence-based continuing education designed to impact the practice behavior of the healthcare team leading to improve patient outcomes.

We’re seeking your expert clinical insights to help shape the future of continuing medical education in Alzheimer’s Disease and T2D Treatment in the form of Weekly Basal Insulin. Your feedback will directly influence the educational content we develop to support healthcare professionals like you.

Important Note:

To support informed participation, we recommend reviewing the following complimentary CME activity prior to completing the survey. This activity provides foundational context on Alzheimer’s disease and ARIA and may enhance your ability to respond to the survey questions.

Estimated time: ~1 hour
Cost: Free
Credit: 1.0 ACCME and EBAC CME credits
*Participation in the CME activity is not required to complete the survey.

Name
1. In the past 3 months, have you changed how you assess ARIA risk prior to initiating anti-amyloid therapy?
2. In the past 3 months, have you ordered a baseline MRI using standardized ARIA monitoring protocols prior to initiating therapy?
3. When mild ARIA-E is detected, what is your usual management approach?
4. In the past 3 months, approximately how many patients have you evaluated for anti-amyloid therapy eligibility?
5. Of those evaluated, how many were initiated on therapy?
6. Have you delayed or avoided initiating therapy due to uncertainty about ARIA risk?
7. In the past 3 months, have you ordered an MRI in response to new neurologic symptoms in a patient receiving anti-amyloid therapy?
8. Has your threshold for ordering urgent MRI for suspected ARIA changed since the activity?
9. SIn the past 3 months, have you implemented standardized ARIA reporting language or templates?
10. Has communication between neurology and radiology improved in ARIA management at your institution?
11. Who primarily drives ARIA management decisions in your setting?
12. Over the past 3 months, how confident have you been in discussing ARIA risk with patients and caregivers?
13. Have you modified how you counsel patients about:
(select all that apply)
14. In the past 3 months, have you discontinued therapy due to ARIA?
15. With the right educational training, which of the following changes could you see implemented in your practice setting?
(select all that apply)

Signup for Free CME Opportunities

Signup for MLI’s mailing list to receive updates on our upcoming CME course launches

Facebook Twitter Linkedin Instagram Threads X-twitter
Subscribe to Mailing List
Scroll to Top